Bharat Dynamics Ltd.: Will Order Deliveries Match the Schedule, or Will Execution Slip Again?

BDL builds missiles and underwater weapon systems for the Ministry of Defence and export customers, and it earns revenue only when contracted units are actually delivered against a schedule, not when orders are signed. Its order book stood at ₹26,176 crore as of March 2026, a figure that dwarfs a single year of sales.

Only about 18% of that backlog was scheduled for delivery within one year as of the most recent breakdown available. History shows that schedule and delivery don’t always match: revenue fell in FY2023-24 on supply disruptions involving foreign-sourced subassemblies, and FY2026 revenue contracted 27% even as the order book hit a record.

Liquidated damages, penalties customers charge for late delivery, on the backlog rose from ₹7,962 lakh to ₹31,973 lakh between FY2024 and FY2025, a sign of how much slippage already costs the company.

These results will show whether revenue delivered matches the within-one-year order slice already disclosed, or deviates from it. Read more.

Tube Investments of India Ltd.: Can Core Profits Outpace EV Cash Burn?

Tube Investments makes precision steel tubes and cold-rolled steel strips, mostly for vehicle makers, and it sells them under back-to-back steel pricing, steel cost changes are passed through to customers rather than absorbed. That Engineering division brought in ₹5,612 crore of revenue in FY2026, up 12% year on year, with profit before interest and tax of ₹689 crore. Underneath that revenue, domestic tube volumes grew 13% and cold-rolled steel strip volumes grew 28%, so the growth is more things sold, not steel prices flowing through the top line.

Two new plants sit at the centre of the next leg. The Phaltan tube plant started production in August 2025; the Nashik strips plant was 70% utilised as of the second quarter of FY2026. A new plant carries its depreciation and fixed costs from day one and fills up over years, which is why return on capital employed in this division has fallen from 73% in FY2023 to 46% in FY2026 while its margin barely moved, holding in a 12.0% to 12.5% band throughout. That is the thing to watch this quarter: revenue growth tells you the plants are filling, but the margin tells you whether they are filling at full price. Read more.

Will The Cost Pressure On Alkem Laboratories Ltd.‘ Raw Materials Stay Within The Range Management Has Guided?

Alkem earns most of its money selling branded generic medicines in India; that business brought in ₹9,851 crore in FY26, or 67.8% of total company sales. A smaller but faster-growing piece comes from the United States, where the company sells generic drugs approved by the US drug regulator, the USFDA.

Management has told investors that profit margin before interest, tax, depreciation and amortisation, a measure of operating profit called EBITDA, should land between 20% and 21% for the full year. That is a step down from the steady improvement the company had guided in prior years, and management has pointed to rising costs for active pharmaceutical ingredients and packaging materials as the reason. The company’s finance chief has said this cost pressure will have a ‘definite impact’ on the quarter now being reported. Read more

Ashok Leyland Ltd.: Can Record Sales Outpace Falling Market Share and Steel Costs?

Ashok Leyland is India’s second-largest maker of commercial vehicles. It sold 2,20,437 vehicles in FY26, an all-time high that passed the previous peak of 1,97,366 set seven years earlier. It is number one in buses with a 34.1% share, number two in medium and heavy trucks, had its best year in light commercial vehicles at 74,322 units, and its best year in exports at 18,082. Alongside the vehicles sit spare parts worth ₹4,450 crore, a defence business and a power generation business that sold 36,351 engines.

The profitability story has been the good one. The complication is steel. The company buys about ₹2,300 crore of flat steel a year and hedges none of it, so it takes the price as it comes. Management said this quarter faces a significant steel-led cost increase, took a price rise of 1% to 1.5% in April, and was openly uncertain about holding it for the full quarter. It has no automatic escalation clauses with customers. Read more.

Patanjali Foods Ltd.: Can FMCG Growth Outpace Low-Margin Oil?

Cooking oil is nearly three-quarters of what Patanjali Foods sells and barely a third of what it earns. Does the profitable side grow fast enough this year, and does the cash come back?

Patanjali Foods is the former Ruchi Soya, bought out of insolvency by the Patanjali group in 2019 and rebuilt into a food and consumer goods company. It refines and sells cooking oils under Ruchi Gold, Mahakosh and Sunrich; it sells food and household products, Nutrela soya, biscuits, ghee, honey, staples, and the Dant Kanti dental range; and it runs one of India’s largest oil palm plantations, 1,10,722 hectares across twelve states. Read more.

Voltas Ltd.: Can Summer Demand Fix Earnings, Cash Flow, and JV Losses?

Voltas makes most of its money selling room air conditioners in India, where fewer than 10% of households own one today. The company holds the number one spot in that market with a 15.9% share, and it sold over 2.5 million units in fiscal 2025, the first Indian brand to cross that mark.

For that reach to matter this year, a weak season has to not repeat. Fiscal 2026 revenue in the cooling-products segment fell 10.5%, to ₹9,501 crores from ₹10,614 crores, on a subdued summer and early monsoon, and segment profit dropped from ₹892 crores to ₹305 crores. Copper and aluminium sit underneath those margins, and Voltas carries that exposure without derivative hedges, so input costs move straight through to profit. The weak season left a second mark on the balance sheet. Read more.